Skip To Main Content
Ned Pagliarulo on Muck Rack

Ned Pagliarulo

  • Senior Research Manager, Pharma and Biotech, AgencyIQ
Washington, D.C.
As seen in: AgencyIQ, Yahoo Finance, Flipboard, Yahoo, NewsBreak, Healthcare Dive, Food Dive, Utility Dive, CIO Dive, Supply Chain Dive, Yahoo Finanzas and
Covering pharma / biotech regulation @AgencyIQ. Formerly @BioPharmaDive.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ned

Contact Ned, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

AgencyIQ — Eager to leverage prior knowledge, industry pushes FDA to broaden draft guidance’s scope

|
By Ned Pagliarulo
| Friends of Cancer Research
While stakeholders welcomed the FDA’s recent draft guidance on leveraging prior knowledge, many urged the agency to broaden its recommendations beyond genome editing products. Several also pushed for clarity on how the guidance will connect to other related regulatory concepts, such as the plausible mechanism framework and platform technology designation.
Open in Who Shared Issue with article?

Heidi Overton is Trump’s pick for next FDA commissioner. Here’s what to know.

|
By Alexander Gaffney Verified, Ned Pagliarulo
| AgencyIQ
President DONALD TRUMP plans to nominate White House policy aide HEIDI OVERTON as his next FDA commissioner. Here, AgencyIQ examines how Overton, a physician who has helped shape this administration’s health policy, might approach running the agency and identifies key questions ahead of her possible confirmation.
Open in Who Shared Issue with article?

Heidi Overton is Trump’s pick for next FDA commissioner. Here’s what to know.

|
By Alexander Gaffney Verified, Ned Pagliarulo
| AgencyIQ
By Alexander Gaffney, MS, RAC and Ned Pagliarulo President Donald Trump plans to nominate White House policy aide Heidi Overton as the next FDA commissioner, putting a figure closely involved in the administration’s health policy agenda in line to lead the agency. Beyond the nomination itself, her selection raises bigger questions about FDA’s regulatory direction, leadership and the future of initiatives already underway across the agency.
Open in Who Shared Issue with article?
See all 3,314 articles